Gasgon Medical develops fluid management devices, including the AirVault®, which removes air bubbles from IV fluids to enhance the accuracy of intravenous medication delivery. This technology addresses the challenges of IV infusion, reducing waste and minimizing risks for patients and healthcare providers while improving clinical outcomes.
Funding
$7.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Intravenous (IV) infusions, a common medical procedure, face challenges related to air bubbles in IV fluids, which can lead to inaccurate medication delivery, increased waste of expensive medicines and blood products, and potential risks for both patients and healthcare providers. These issues contribute to higher healthcare costs and can negatively impact clinical outcomes.
Solution
Gasgon Medical offers the AirVault®, a single-use medical device designed to remove air bubbles from IV fluids, enhancing the accuracy and safety of intravenous medication delivery. By eliminating air bubbles, AirVault® helps ensure that patients receive the correct dosage of medication, reducing the potential for under- or over-infusion. This technology aims to minimize waste of costly fluid medicines and blood, while also reducing the risk of complications for patients and exposure for nurses. The device integrates directly into existing IV lines, offering a simple and effective solution for improving IV infusion practices.
Target Audience
The primary target audience includes hospitals, clinics, and healthcare providers administering intravenous infusions, particularly nurses and doctors focused on improving patient outcomes and reducing healthcare costs.
Features
- Single-use, disposable design to prevent cross-contamination
- Effective removal of air bubbles from IV fluids
- Compatibility with standard IV lines and infusion systems
- Improves accuracy of medication delivery
- Reduces waste of fluid medicines and blood products
- Minimizes risk of complications associated with air embolisms